Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant

Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucago...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JCEM case reports 2024, Vol.2 (1), p.luad171-luad171
Hauptverfasser: Rafi, Ebne, Lewis, Claudia, Hatipoglu, Betul
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page luad171
container_issue 1
container_start_page luad171
container_title JCEM case reports
container_volume 2
creator Rafi, Ebne
Lewis, Claudia
Hatipoglu, Betul
description Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT.
doi_str_mv 10.1210/jcemcr/luad171
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928957197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2928957197</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_29289571973</originalsourceid><addsrcrecordid>eNqVjb1qwzAURkWhkNBm7XzHLmkkFaNoNKVtOrRk8B4usmwUrnVd_RT89vXQF-h04ON8HCEelHxSWsnD1fnJpQNV7JVRN2KrTdPsVaPlRuxyvkoptbXSGr0V9Yt_PEE7zxQclsAReIDP4BL3nEMc4Z2qw3HdB05wWmYeaVkDAaEdik_QcUGCM0aXPBbvCk8LYOyhrYWJR64ZPjL5Al3CmGfCWO7F7YCU_e6Pd-Lx7bV7Oe3nxN_V53KZQnaeVtev_4u2-mgbo6x5_of6C7dKWBk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2928957197</pqid></control><display><type>report</type><title>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</title><source>Oxford Journals Open Access Collection</source><source>PMC (PubMed Central)</source><creator>Rafi, Ebne ; Lewis, Claudia ; Hatipoglu, Betul</creator><creatorcontrib>Rafi, Ebne ; Lewis, Claudia ; Hatipoglu, Betul</creatorcontrib><description>Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT.</description><identifier>EISSN: 2755-1520</identifier><identifier>DOI: 10.1210/jcemcr/luad171</identifier><language>eng</language><ispartof>JCEM case reports, 2024, Vol.2 (1), p.luad171-luad171</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Rafi, Ebne</creatorcontrib><creatorcontrib>Lewis, Claudia</creatorcontrib><creatorcontrib>Hatipoglu, Betul</creatorcontrib><title>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</title><title>JCEM case reports</title><description>Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT.</description><issn>2755-1520</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2024</creationdate><recordtype>report</recordtype><recordid>eNqVjb1qwzAURkWhkNBm7XzHLmkkFaNoNKVtOrRk8B4usmwUrnVd_RT89vXQF-h04ON8HCEelHxSWsnD1fnJpQNV7JVRN2KrTdPsVaPlRuxyvkoptbXSGr0V9Yt_PEE7zxQclsAReIDP4BL3nEMc4Z2qw3HdB05wWmYeaVkDAaEdik_QcUGCM0aXPBbvCk8LYOyhrYWJR64ZPjL5Al3CmGfCWO7F7YCU_e6Pd-Lx7bV7Oe3nxN_V53KZQnaeVtev_4u2-mgbo6x5_of6C7dKWBk</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Rafi, Ebne</creator><creator>Lewis, Claudia</creator><creator>Hatipoglu, Betul</creator><scope>7X8</scope></search><sort><creationdate>20240101</creationdate><title>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</title><author>Rafi, Ebne ; Lewis, Claudia ; Hatipoglu, Betul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_29289571973</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Rafi, Ebne</creatorcontrib><creatorcontrib>Lewis, Claudia</creatorcontrib><creatorcontrib>Hatipoglu, Betul</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rafi, Ebne</au><au>Lewis, Claudia</au><au>Hatipoglu, Betul</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</atitle><jtitle>JCEM case reports</jtitle><date>2024-01-01</date><risdate>2024</risdate><volume>2</volume><issue>1</issue><spage>luad171</spage><epage>luad171</epage><pages>luad171-luad171</pages><eissn>2755-1520</eissn><abstract>Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT.</abstract><doi>10.1210/jcemcr/luad171</doi></addata></record>
fulltext fulltext
identifier EISSN: 2755-1520
ispartof JCEM case reports, 2024, Vol.2 (1), p.luad171-luad171
issn 2755-1520
language eng
recordid cdi_proquest_miscellaneous_2928957197
source Oxford Journals Open Access Collection; PMC (PubMed Central)
title Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A35%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Novel%20Application%20of%20Microdosing%20Glucagon%20for%20Hypoglycemia%20After%20Total%20Pancreatectomy%20and%20Autologous%20Islet%20Transplant&rft.jtitle=JCEM%20case%20reports&rft.au=Rafi,%20Ebne&rft.date=2024-01-01&rft.volume=2&rft.issue=1&rft.spage=luad171&rft.epage=luad171&rft.pages=luad171-luad171&rft.eissn=2755-1520&rft_id=info:doi/10.1210/jcemcr/luad171&rft_dat=%3Cproquest%3E2928957197%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928957197&rft_id=info:pmid/&rfr_iscdi=true